XPO1 and cancer: As these compounds block CRM1-dependent export and influence the cellular distribution pattern of the proteins/oncoproteins/tumor suppressor proteins, they modulate the fate of cancer cells by decreasing their survival rate [139,143,144,149,151,154,155,220].